Clinical trial
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the…
NCT00003237 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003237 |
|---|---|
| Title | Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach |
| Official title | Phase II Trial of Post-Operative Adjuvant Paclitaxel + Cisplatin in Patients With Adenocarcinoma of the Esophagus, Gastro-Esophageal Junction or Cardia |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, paclitaxel, surgical procedure |
| Enrollment | 55 |
| Start date | Jun 22, 1998 |
| Primary completion | Oct 1, 2003 |
| First posted | Aug 25, 2004 |
| Last update posted | Jun 22, 2023 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: